Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Autoimmune Disorders

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 65 articles:
HTML format
Text format



Single Articles


    August 2019
  1. MOCCIA M, Prados F, Filippi M, Rocca MA, et al
    Longitudinal spinal cord atrophy in multiple sclerosis using the generalised boundary shift integral.
    Ann Neurol. 2019 Aug 6. doi: 10.1002/ana.25571.
    PubMed     Text format     Abstract available


    July 2019
  2. JUREK B, Chayka M, Kreye J, Lang K, et al
    Human gestational NMDAR autoantibodies impair neonatal murine brain function.
    Ann Neurol. 2019 Jul 20. doi: 10.1002/ana.25552.
    PubMed     Text format     Abstract available


    June 2019
  3. GIL-PEROTIN S, Alcala C, Perez-Miralles FC, Casanova B, et al
    Silent progression or bout-onset progressive multiple sclerosis?
    Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25537.
    PubMed     Text format    


  4. CREE BAC, Hauser SL
    Reply to "Silent progression or bout-onset progressive multiple sclerosis?"
    Ann Neurol. 2019 Jun 28. doi: 10.1002/ana.25536.
    PubMed     Text format    


  5. MUNGER KL, Hongell K, Cortese M, Aivo J, et al
    Epstein-Barr virus and multiple sclerosis risk in the Finnish Maternity Cohort.
    Ann Neurol. 2019 Jun 21. doi: 10.1002/ana.25532.
    PubMed     Text format     Abstract available


    May 2019
  6. VAN LANGELAAR J, Rijvers L, Janssen M, Wierenga-Wolf AF, et al
    Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis.
    Ann Neurol. 2019 May 28. doi: 10.1002/ana.25508.
    PubMed     Text format     Abstract available


  7. LIM JA, Lee ST, Chu K, Lee SK, et al
    Reply to "Grading the severity of autoimmune encephalitis: advances and pitfalls".
    Ann Neurol. 2019 May 2. doi: 10.1002/ana.25497.
    PubMed     Text format    


  8. SPAGNI G, Iorio R
    Grading the severity of autoimmune encephalitis: advances and pitfalls.
    Ann Neurol. 2019 May 2. doi: 10.1002/ana.25496.
    PubMed     Text format    


    March 2019
  9. AKTAS O, Hartung HP
    CSI: Multiple sclerosis. Tracing optic nerve involvement by standardized optical coherence tomography.
    Ann Neurol. 2019 Mar 22. doi: 10.1002/ana.25471.
    PubMed     Text format    


  10. CREE BAC, Hollenbach JA, Bove R, Kirkish G, et al
    Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis.
    Ann Neurol. 2019 Mar 9. doi: 10.1002/ana.25463.
    PubMed     Text format     Abstract available


    February 2019
  11. DALLA COSTA G, Martinelli V, Moiola L, Sangalli F, et al
    Serum neurofilaments increase at PML onset in natalizumab-treated MS patients.
    Ann Neurol. 2019 Feb 13. doi: 10.1002/ana.25437.
    PubMed     Text format     Abstract available


  12. FADDA G, Brown RA, Magliozzi R, Aubert-Broche B, et al
    A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis.
    Ann Neurol. 2019 Feb 4. doi: 10.1002/ana.25429.
    PubMed     Text format     Abstract available


    January 2019
  13. LIM JA, Lee ST, Moon J, Jun JS, et al
    Development of the Clinical Assessment Scale in Autoimmune Encephalitis (CASE).
    Ann Neurol. 2019 Jan 24. doi: 10.1002/ana.25421.
    PubMed     Text format     Abstract available


  14. BAERT L, Benkhoucha M, Popa N, Ahmed MC, et al
    APRIL-mediated anti-inflammatory response of astrocytes in multiple sclerosis.
    Ann Neurol. 2019 Jan 11. doi: 10.1002/ana.25415.
    PubMed     Text format     Abstract available


    October 2018
  15. BEVAN RJ, Evans R, Griffiths L, Watkins LM, et al
    MENINGEAL INFLAMMATION AND CORTICAL DEMYELINATION IN ACUTE MULTIPLE SCLEROSIS.
    Ann Neurol. 2018 Oct 25. doi: 10.1002/ana.25365.
    PubMed     Text format     Abstract available


    September 2018
  16. HE D, Zhang H, Xiao J, Zhang X, et al
    Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.
    Ann Neurol. 2018;84:386-400.
    PubMed     Text format     Abstract available


    August 2018
  17. WOLINSKY JS, Montalban X, Hauser SL, Giovannoni G, et al
    Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
    Ann Neurol. 2018 Aug 29. doi: 10.1002/ana.25313.
    PubMed     Text format     Abstract available


  18. SEBASTIAN LOPEZ-CHIRIBOGA A, Klein C, Zekeridou A, McKeon A, et al
    LGI1 and CASPR2 Neurological Autoimmunity in Children.
    Ann Neurol. 2018 Aug 3. doi: 10.1002/ana.25310.
    PubMed     Text format     Abstract available


    July 2018
  19. FUJII T, Yamasaki R, Iinuma K, Tsuchimoto D, et al
    A novel autoantibody against plexin D1 in patients with neuropathic pain.
    Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25279.
    PubMed     Text format     Abstract available


    June 2018
  20. JIA X, Madireddy L, Caillier S, Santaniello A, et al
    Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
    Ann Neurol. 2018 Jun 16. doi: 10.1002/ana.25263.
    PubMed     Text format     Abstract available


    May 2018
  21. DISANTO G, Zecca C, MacLachlan S, Sacco R, et al
    Prodromal symptoms of multiple sclerosis in primary care.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25247.
    PubMed     Text format     Abstract available


    April 2018
  22. TANKOU SK, Regev K, Healy BC, Tjon E, et al
    A probiotic modulates the microbiome and immunity in multiple sclerosis.
    Ann Neurol. 2018 Apr 20. doi: 10.1002/ana.25244.
    PubMed     Text format     Abstract available


  23. VOGRIG A, Brigo F, Valente M, Gigli GL, et al
    Epidemiology of autoimmune versus infectious encephalitis.
    Ann Neurol. 2018 Apr 10. doi: 10.1002/ana.25229.
    PubMed     Text format    


  24. DUBEY D, Pittock SJ, Toledano M, Flanagan EP, et al
    Reply to "Epidemiology of autoimmune versus infectious encephalitis".
    Ann Neurol. 2018 Apr 10. doi: 10.1002/ana.25230.
    PubMed     Text format    


    March 2018
  25. CRAMER SP, Simonsen HJ, Varatharaj A, Galea I, et al
    Permeability of the blood-brain barrier predicts no evidence of disease activity at two years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25219.
    PubMed     Text format     Abstract available


  26. ANTEL J
    The reality of "ghosts" in authorship of clinical trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 13. doi: 10.1002/ana.25199.
    PubMed     Text format    


  27. COLES A
    Authorship of phase 3 trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25203.
    PubMed     Text format    


  28. MAGLIOZZI R, Howell OW, Nicholas R, Cruciani C, et al
    Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25197.
    PubMed     Text format     Abstract available


    February 2018
  29. JENDE JME, Groener JB, Oikonomou D, Heiland S, et al
    Diabetic neuropathy differs between type 1 and type 2 diabetes Insights from magnetic resonance neurography.
    Ann Neurol. 2018 Feb 14. doi: 10.1002/ana.25182.
    PubMed     Text format     Abstract available


  30. BECK ES, Reich DS
    Brain atrophy in multiple sclerosis: How deep must we go?
    Ann Neurol. 2018;83:208-209.
    PubMed     Text format    


  31. MAGGI P, Absinta M, Grammatico M, Vuolo L, et al
    Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
    Ann Neurol. 2018;83:283-294.
    PubMed     Text format     Abstract available


    January 2018
  32. ESHAGHI A, Prados F, Brownlee W, Altmann DR, et al
    Deep grey matter volume loss drives disability worsening in multiple sclerosis.
    Ann Neurol. 2018 Jan 13. doi: 10.1002/ana.25145.
    PubMed     Text format     Abstract available


  33. AZEVEDO CJ, Cen SY, Khadka S, Liu S, et al
    Thalamic Atrophy in MS: An MRI Marker of Neurodegeneration Throughout Disease.
    Ann Neurol. 2018 Jan 12. doi: 10.1002/ana.25150.
    PubMed     Text format     Abstract available


  34. DUBEY D, Pittock SJ, Kelly CR, McKeon A, et al
    Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis.
    Ann Neurol. 2018 Jan 2. doi: 10.1002/ana.25131.
    PubMed     Text format     Abstract available


    December 2017
  35. GILES DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, et al
    Myeloid cell plasticity in the evolution of central nervous system autoimmunity.
    Ann Neurol. 2017 Dec 28. doi: 10.1002/ana.25128.
    PubMed     Text format     Abstract available


  36. GREENFIELD AL, Hauser SL
    B Cell Therapy for Multiple Sclerosis: Entering an Era.
    Ann Neurol. 2017 Dec 15. doi: 10.1002/ana.25119.
    PubMed     Text format     Abstract available


  37. PATTERSON KR, Dalmau J, Lancaster E
    Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.
    Ann Neurol. 2017 Dec 15. doi: 10.1002/ana.25120.
    PubMed     Text format     Abstract available


    November 2017
  38. KANAI T, Uzawa A, Sato Y, Suzuki S, et al
    A clinical predictive score for postoperative myasthenic crisis.
    Ann Neurol. 2017;82:841-849.
    PubMed     Text format     Abstract available


    October 2017
  39. BARBOUR C, Kosa P, Komori M, Tanigawa M, et al
    Molecular-based diagnosis of Multiple Sclerosis and its progressive stage.
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25083.
    PubMed     Text format     Abstract available


  40. AZODI S, Nair G, Enose-Akahata Y, Charlip E, et al
    Imaging Spinal Cord Atrophy in Progressive Myelopathies: HTLV-I Associated Neurologic Disease (HAM/TSP) and Multiple Sclerosis (MS).
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25072.
    PubMed     Text format     Abstract available


  41. JENDE JME, Hauck GH, Diem R, Weiler M, et al
    Peripheral nerve involvement in multiple sclerosis Demonstration by magnetic resonance neurography.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25068.
    PubMed     Text format     Abstract available


  42. MAINERO C, Louapre C
    Unravelling cortical pathology in multiple sclerosis using the T1-/T2-weighted ratio?
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25063.
    PubMed     Text format    


  43. WIJNANDS JMA, Tremlett H
    Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25061.
    PubMed     Text format    


  44. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Reply to: Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25062.
    PubMed     Text format    


    September 2017
  45. FITZGERALD KC, Munger KL, Ascherio A
    Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".
    Ann Neurol. 2017 Sep 29. doi: 10.1002/ana.25055.
    PubMed     Text format    


  46. ZAHEDNASAB H, Harirchian MH, Karampoor S, Keyvani H, et al
    MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25037.
    PubMed     Text format    


  47. FISSOLO N, Pignolet B, Brassat D, Comabella M, et al
    Reply: MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25039.
    PubMed     Text format    


  48. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Concussion in adolescence and risk of multiple sclerosis.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25036.
    PubMed     Text format     Abstract available


    August 2017
  49. NAKAMURA K, Chen JT, Ontaneda D, Fox RJ, et al
    T1-/T2-weighted ratio differs in demyelinated cortex of multiple sclerosis.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25019.
    PubMed     Text format     Abstract available


  50. RIGHART R, Biberacher V, Jonkman LE, Klaver R, et al
    Cortical pathology in MS detected by the T1/T2-weighted ratio from routine MRI.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25020.
    PubMed     Text format     Abstract available


  51. DALAKAS MC, Rakocevic G, Dambrosia JM, Alexopoulos H, et al
    A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.
    Ann Neurol. 2017;82:271-277.
    PubMed     Text format     Abstract available


    July 2017
  52. YATES RL, Esiri MM, Palace J, Jacobs B, et al
    Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.
    Ann Neurol. 2017 Jul 18. doi: 10.1002/ana.24997.
    PubMed     Text format     Abstract available


  53. FISSOLO N, Pignolet B, Matute-Blanch C, Trivino JC, et al
    MMP9 is decreased in natalizumab-treated MS patients at risk for PML.
    Ann Neurol. 2017 Jul 6. doi: 10.1002/ana.24987.
    PubMed     Text format     Abstract available


    May 2017
  54. FITZGERALD KC, Munger KL, Hartung HP, Freedman MS, et al
    Sodium intake and multiple sclerosis activity and progression in BENEFIT.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24965.
    PubMed     Text format     Abstract available


  55. DISANTO G, Barro C, Benkert P, Naegelin Y, et al
    Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Ann Neurol. 2017 May 16. doi: 10.1002/ana.24954.
    PubMed     Text format     Abstract available


  56. CUI QL, Khan D, Rone M, Rao V, et al
    Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24944.
    PubMed     Text format     Abstract available


  57. IAFFALDANO P, Simone M, Lucisano G, Ghezzi A, et al
    Prognostic indicators in pediatric clinically isolated syndrome.
    Ann Neurol. 2017;81:729-739.
    PubMed     Text format     Abstract available


    April 2017
  58. ANDRODIAS G, Bernard E, Biotti D, Collongues N, et al
    Multiple sclerosis broke my heart.
    Ann Neurol. 2017 Apr 24. doi: 10.1002/ana.24935.
    PubMed     Text format     Abstract available


  59. SELMAJ I, Cichalewska M, Namiecinska M, Galazka G, et al
    Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis.
    Ann Neurol. 2017 Apr 15. doi: 10.1002/ana.24931.
    PubMed     Text format     Abstract available


    March 2017
  60. TAWARA N, Yamashita S, Zhang X, Korogi M, et al
    Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis.
    Ann Neurol. 2017 Mar 20. doi: 10.1002/ana.24919.
    PubMed     Text format     Abstract available


  61. TREMLETT H, Bauer KC, Appel-Cresswell S, Finlay BB, et al
    The gut microbiome in human neurological disease: A review.
    Ann Neurol. 2017;81:369-382.
    PubMed     Text format     Abstract available


    February 2017
  62. KIM TJ, Lee ST, Moon J, Sunwoo JS, et al
    Anti-LGI1 encephalitis is associated with unique HLA subtypes.
    Ann Neurol. 2017;81:183-192.
    PubMed     Text format     Abstract available


    December 2016
  63. HERRANZ E, Hooker JM, Izquierdo-Garcia D, Loggia ML, et al
    11 C-PBR28 increase in multiple sclerosis reflects neuroinflammation.
    Ann Neurol. 2016 Dec 29. doi: 10.1002/ana.24865.
    PubMed     Text format    


  64. RAFFEL J, Sridharan S, Nicholas R
    [11 C]PBR-28 PET in multiple sclerosis: Neuroinflammation or otherwise?
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24853.
    PubMed     Text format    


    July 2016
  65. WHITE MK, Wollebo HS, Beckham JD, Tyler KL, et al
    Zika virus: An emergent neuropathological agent.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24748.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: